Omeprazole sodium bicarbonate
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole Sodium Bicarbonate: Efficacy and Stability in Treating Acid-Related Disorders
Introduction to Omeprazole Sodium Bicarbonate
Omeprazole, a proton pump inhibitor (PPI), is widely used to treat acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. Combining omeprazole with sodium bicarbonate enhances its efficacy by providing immediate-release properties, which can be beneficial for rapid symptom relief.
Acid Inhibitory Effects of Omeprazole and Sodium Bicarbonate
Comparison with Delayed-Release Omeprazole
A study comparing the acid inhibitory effects of a combination of immediate-release omeprazole (40 mg) and sodium bicarbonate (1100 mg) (CDFR0209) with delayed-release omeprazole (40 mg) found that both formulations were equally effective in decreasing integrated gastric acidity at steady state . This suggests that the combination formulation can be a viable alternative to the delayed-release version, offering similar therapeutic benefits.
Efficacy in Gastroesophageal Reflux Disease (GERD)
A systematic review assessing the efficacy of omeprazole/sodium bicarbonate in GERD patients concluded that while the combination therapy is not more effective than omeprazole alone, it tends to provide a more sustained response and quicker relief within 30 minutes 23. This rapid onset of action can be particularly advantageous for patients seeking immediate symptom relief.
Stability of Omeprazole Sodium Bicarbonate Formulations
Stability in Oral Suspensions
Research on the stability of omeprazole-sodium bicarbonate oral suspensions has shown that these formulations retain over 98% of their initial omeprazole concentration when stored refrigerated for up to one month . Even at room temperature, higher concentration suspensions (2-4 mg/mL) maintained over 90% stability for one week, although lower concentrations were less stable . This indicates that omeprazole-sodium bicarbonate suspensions are robust and can be stored effectively under various conditions.
Stability in Partial Doses and Through Feeding Tubes
Further studies have demonstrated that omeprazole-sodium bicarbonate suspensions remain stable for up to 45 days when refrigerated and can be administered through neonatal and pediatric feeding tubes without clogging, unlike lansoprazole bead mixtures . This makes the combination particularly suitable for pediatric and neonatal care, where precise dosing and ease of administration are critical.
Clinical Applications and Additional Benefits
Treatment of Laryngopharyngeal Reflux
In treating laryngopharyngeal reflux (LPR), a combination of omeprazole enteric-coated tablets and sodium bicarbonate spray has shown significant improvement in symptoms and pathology, with an effective rate of 92% . This highlights the potential of the combination therapy in managing conditions beyond GERD and peptic ulcers.
Helicobacter pylori Infection
However, when used in combination with amoxicillin for treating Helicobacter pylori infection, neither omeprazole nor ranitidine plus sodium bicarbonate showed satisfactory cure rates, indicating that these combinations may not be effective for this particular infection .
Conclusion
Omeprazole combined with sodium bicarbonate offers several advantages, including rapid onset of action and sustained symptom relief in acid-related disorders. Its stability in various formulations and suitability for pediatric use further enhance its clinical utility. While it may not be effective for all conditions, such as Helicobacter pylori infection, it remains a valuable option for treating GERD, peptic ulcers, and laryngopharyngeal reflux.
Sources and full results
Most relevant research papers on this topic